Hormonal profile and fertility in patients with Anderson-Fabry disease

International Journal of Clinical Practice

Volumn 59, Issue 9, 2005, Pages 1025-1028

  Hauser, Anna Christine ^a   Gessl, A ^a   Harm, F ^b   Wiesholzer, M ^b   Kleinert, J ^a   Wallner, M ^c   Voigtlander T ^d   Bieglmayer, C ^a   Sunder Plassmann, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^c Krankenhaus Wels   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anderson Fabry disease; Endocrine function; Endocrine glands; Fertility; Hypothalamus; Pituitary

Indexed keywords

ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; CORTICOSTEROID; SEX HORMONE;

ADRENAL FUNCTION; ADULT; AGED; ARTICLE; AUSTRIA; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; FABRY DISEASE; FEMALE; FERTILITY; HEMODIALYSIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MALE; OUTPATIENT; OVARY FUNCTION; PRIORITY JOURNAL; TESTIS FUNCTION; BLOOD; CHI SQUARE DISTRIBUTION; MIDDLE AGED; REFERENCE VALUE; RENAL REPLACEMENT THERAPY;

ADRENAL CORTEX HORMONES; ADULT; AGED; CHI-SQUARE DISTRIBUTION; FABRY DISEASE; FEMALE; FERTILITY; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RENAL DIALYSIS;

EID: 33644845886     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00620.x     Document Type: Article

References (21)

1. Hauser AC, Lorenz M, Sunder-Plassmann G. The expanding clinical spectrum of Anderson-Fabry Disease - A challenge to diagnosis in the novel era of enzyme replacement therapy. J Int Med 2004; 255: 629-36.
2. Desnick RJ, Brady R, Barranger J et al. Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338-46.
3. Branton M, Schiffmann R, Kopp JB. Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 2002; 13 (Suppl. 2): S139-43.
4. Kolodny EH, Pastores GM. Anderson-Fabry disease: Extrarenal, neurologic manifestations. J Am Soc Nephrol 2002; 13 (Suppl. 2): S150-3.
5. Whybra C, Kampmann C, Willers I et al. Anderson-Fabry disease: Clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001; 24: 715-24.
6. Hauser AC, Lorenz M, Voigtländer T, Födinger M, Sunder-Plassmann G. Results of an ophthalmologic screening program for identification of cases with Fabry disease. Opthalmologica 2004; 218: 207-9.
7. Hauser AC, Gessl A, Lorenz M, Voigtländer T, Födinger M, Sunder-Plassmann G. High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease. J Inherit Metab Dis 2005 (in press)
8. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995 May 18; 332: 1351-62.
9. Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W. Fabry's disease: Enzymatic diagnosis of hemizygotes and heterozygotes: Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973; 81: 157-71.
10. Kotanko P, Kramar R, Devrnja D et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 2004; 15: 1323-9.
11. Statistisches Jahrbuch Österreichs. 2005, Statistic Austria.
12. deVeber GA, Schwarting GA, Kolodny EH, Kowall NW. Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 1992; 31: 409-15.
13. Nistal M, Paniagua R, Picazo ML. Testicular and epididymal involvement in Fabry's disease. J Pathol 1983; 141: 113-24.
14. Guin GH, Burns WA, Saini N, Jones WP. Diffuse angiokeratoma (Fabry's disease). Mil Med 1976; 141: 259-63.
15. Lim VS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab 1976; 43: 1370-7.
16. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA. Metabolic clearance and secretion rates of human prolactin in normal subjects and patients with chronic renal failure. J Clin Endocrinol Metab 1980; 50: 846-52.
17. de Vries CP, Gooren LJ, Oe PL. Haemodialysis and testicular function. Int J Androl 1984; 7: 97-103.
18. Allan WC, Haddow JE, Palomaki GE et al. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Med Screen 2000; 7: 127-30.
19. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-55.
20. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39: S1-266.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.